In What Direction Will Danimer Scientific Inc.’s (NYSE:DNMR) Stock Goes From Here?

The closing price of Danimer Scientific Inc. (NYSE: DNMR) was $2.26 for the day, up 1.80% from the previous closing price of $2.22. In other words, the price has increased by $+0.0400 from its previous closing price. On the day, 1035129 shares were traded. DNMR stock price reached its highest trading level at $2.3200 during the session, while it also had its lowest trading level at $2.1705.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Ratios:

Our analysis of DNMR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.00 and its Current Ratio is at 5.20. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.73.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on October 12, 2022, initiated with a Overweight rating and assigned the stock a target price of $4.50.

On September 23, 2021, Cowen started tracking the stock assigning a Outperform rating and target price of $21.

On January 06, 2021, Jefferies started tracking the stock assigning a Buy rating and target price of $31.Jefferies initiated its Buy rating on January 06, 2021, with a $31 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 17 when Tuten Scott sold 10,000 shares for $2.14 per share. The transaction valued at 21,394 led to the insider holds 395,210 shares of the business.

Tuten Scott sold 10,000 shares of DNMR for $16,331 on Dec 19. The Chief Marketing Officer now owns 424,136 shares after completing the transaction at $1.63 per share. On Nov 17, another insider, Tuten Scott, who serves as the Chief Marketing Officer of the company, sold 10,000 shares for $2.68 each. As a result, the insider received 26,820 and left with 434,136 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 3.90 while its Price-to-Book (P/B) ratio in mrq is 0.58.

Stock Price History:

Over the past 52 weeks, DNMR has reached a high of $6.78, while it has fallen to a 52-week low of $1.57. The 50-Day Moving Average of the stock is 2.1782, while the 200-Day Moving Average is calculated to be 3.6459.

Shares Statistics:

DNMR traded an average of 1.36M shares per day over the past three months and 1.39M shares per day over the past ten days. A total of 101.39M shares are outstanding, with a floating share count of 90.45M. Insiders hold about 0.40% of the company’s shares, while institutions hold 45.10% stake in the company. Shares short for DNMR as of Oct 13, 2022 were 19.66M with a Short Ratio of 18.94M, compared to 17.76M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 19.43% and a Short% of Float of 21.68%.

Earnings Estimates

The firm’s stock currently is rated by 4 analysts. On average, analysts expect EPS of -$0.17 for the current quarter, with a high estimate of $0 and a low estimate of -$0.29, while EPS last year was -$0.2. The consensus estimate for the next quarter is -$0.13, with high estimates of $0 and low estimates of -$0.29.

Analysts are recommending an EPS of between -$0.51 and -$1.14 for the fiscal current year, implying an average EPS of -$0.9. EPS for the following year is -$0.84, with 4 analysts recommending between -$0.51 and -$1.19.

Revenue Estimates

It is expected that $90B in revenue will be generated in the current quarter, according to 3 analysts. It ranges from a high estimate of $14.16M to a low estimate of $10.3M. As of the current estimate, Danimer Scientific Inc.’s year-ago sales were $13.37M, an estimated decrease of -6.40% from the year-ago figure. For the next quarter, 3 analysts are estimating revenue of $19.3M, an increase of 8.90% over than the figure of -$6.40% in the same quarter last year. There is a high estimate of $22.5M for the next quarter, whereas the lowest estimate is $17.29M.

A total of 4 analysts have provided revenue estimates for DNMR’s current fiscal year. The highest revenue estimate was $75.3M, while the lowest revenue estimate was $55.04M, resulting in an average revenue estimate of $63.27M. In the same quarter a year ago, actual revenue was $58.75M, up 7.70% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $164.22M in the next fiscal year. The high estimate is $229M and the low estimate is $124.57M. The average revenue growth estimate for next year is up 159.60% from the average revenue estimate for this year.